Article Details
Retrieved on: 2021-06-03 11:02:47
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
IGM-6268 is an IgM version of an anti-SARS-CoV-2 IgG monoclonal antibody being developed as an intranasally administered agent for the treatment ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here